If you have been reading about LC-MS/MS and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-03-28. Where a claim depends on a specific study, the study is described rather than over-claimed.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also marketed informally as Stenabolic |
| Chemical class | Synthetic REV-ERB agonist | Binds REV-ERBα and REV-ERBβ |
| Molecular formula | C24H30ClN3O4S | Approximate molecular weight 492 g/mol |
| CAS Registry Number | 1379686-30-2 | Identifier for the parent compound |
| Regulatory status | Not approved for human use | Prohibited in sport by WADA |
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
== Terminology and definition == The term fungarium was introduced by Brian Spooner and Paul Cannon and presented by David Hawksworth in 2010 as a logical analogue to herbarium for collections of preserved fungi. Historically, mycology was treated as a sub-discipline of botany, so fungal specimens were commonly stored within herbaria. The proposal of fungarium formed part of a broader assertion of mycological independence; a related development is the use of "funga" for the fungi of a particular area, in parallel with "flora" for plants and "fauna" for animals. Hawksworth recommended fungarium for facilities whose taxonomic value centres on representative members of the Fungi, although many institutions have continued to use "herbarium" for historical reasons or for combined botanical-mycological collections. The term gained wider professional use when the Royal Botanic Gardens, Kew adopted it for its mycological collection. While some institutions use the term to explicitly distinguish mycological holdings from plant collections, others maintain the name "herbarium" for historical continuity. Similarly, the term "lichenarium" is occasionally used by institutions that maintain separate collections of lichen specimens. In scientific usage, a fungarium is centred on preserved fungal material, usually dried tissue such as whole reproductive structures or representative parts, though it may also include permanent microscope slides and, more rarely, specimens preserved in liquid.
Beesley was named the first non-family member to become the company's president, beginning the transition to non-family management. In 1954, the National Foundation for Infantile Paralysis, now the March of Dimes, contracted with five pharmaceutical companies, Lilly, Cutter Laboratories, Parke-Davis, Pitman-Moore Company, and Wyeth to produce Salk's polio vaccine for clinical trials. Lilly's selection to produce the vaccine was, in part, due to its previous experience in collaborations with university researchers. In 1955, Lilly manufactured 60% of Salk's polio vaccine. In 1962, the company acquired The Distillers Company and established a major factory in Liverpool, England. In 1968, Lilly built its first research facility outside the United States, the Lilly Research Centre, in Surrey, England. In 1969, the company opened a new plant in Clinton, Indiana. During the 1970s, Lilly introduced several new pharmaceutical products, including the antibiotic Keflex in 1972, dobutamine, marketed as Dobutrex, in 1977, and the oral antibiotic cefaclor, marketed as Ceclor, in 1979. In 1971, to further diversify its product line, Lilly acquired Elizabeth Arden, Inc. for $38 million. Although Arden continued to lose money for five years after Lilly acquired it, by 1982, Arden's sales were up 90 percent from 1978, with profits doubling to nearly $30 million. In 1987, Lilly sold Arden to Fabergé for $657 million. In 1972, Richard Donald Wood became Lilly's president and CEO after the retirement of Burton E. Beck.
A cephalopod is any member of the molluscan class Cephalopoda (Greek plural κεφαλόποδες, kephalópodes; "head-feet") such as a squid, octopus, cuttlefish, or nautilus. These exclusively marine animals are characterized by bilateral body symmetry, a prominent head, and a set of arms or tentacles (muscular hydrostats) modified from the primitive molluscan foot. Fishers sometimes call cephalopods "inkfish", referring to their common ability to squirt ink. The study of cephalopods is a branch of malacology known as teuthology. Cephalopods became dominant during the Ordovician period, represented by primitive nautiloids. The class contains two, only distantly related, extant subclasses: Coleoidea, which includes octopuses, squid, and cuttlefish; and Nautiloidea, represented by Nautilus and Allonautilus. In the Coleoidea, the molluscan shell has been internalized or is absent, whereas in the Nautiloidea, the external shell remains. About 800 living species of cephalopods have been identified. Two important extinct taxa are the Ammonoidea (ammonites) and Belemnoidea (belemnites). Extant cephalopods range in size from the 10 mm (0.3 in) Idiosepius thailandicus to the 700 kilograms (1,500 lb) heavy colossal squid, the largest extant invertebrate.
=== Pharmacodynamics === Nalorphine acts at two opioid receptors — the μ-opioid receptor (MOR) where it has antagonistic effects, and at the κ-opioid receptor (KOR) (Ki = 1.6 nM; EC50 = 483 nM; Emax = 95%) where it exerts high-efficacy partial agonist/near-full agonist characteristics.
Sources: en.wikipedia.org
=== Children === Its use in children is generally advised against, although it may be done under the supervision of a specialist. On 21 September 2015, the FDA started investigating the safety of tramadol in use in persons under the age of 17. The investigation was initiated because some of these people have experienced slowed or difficult breathing. The FDA lists age under 12 years old as a contraindication.
Bâ Fatoumata Nènè Sy - former Minister of the Economy, Industry and Trade, Mali. Sy Maïmouna Ba - Minister of Agriculture, Livestock and the Environment, Mali. Mountaga Tall – Politician. former Minister, former First Vice-president of the National Assembly of Mali Diallo Sène - Former Minister for the Promotion of Women, Children, and the Family, Mali. Issaka Sidibé - President of The High Court, former president of The National Assembly. Sy Oumou Louise Sidibé - Former Minister of Public Health, Social Action and the Advancement of Women, Mali Bâ Odette Yattara - Former minister of women and children Affairs, Mali. Amadou Baba Sy - former Minister Of Mines. Cheick Diallo – NBA Basketball player. former New Orleans Pelicans player, Current Phoenix Suns player. USA, Mali Baréma Bocoum - Former minister of foreign affairs, Mali. Soumaré Aminata Sidibé - Former Minister of State Lands anFd Land Affairs of Mali. Ba Hawa Keïta - Former minister of labor and Vocational training, Mali. Michel Sidibe - physician, former Minister of Health And Social Welfare, former executive director UNAIDS. Boubou Cisse - Politician and economist. former prime minister and Minister of Economy and Finance; former Minister of Industry and Mines; Mali. Diallo Madeleine Bâ - Former Minister Of Health, Mali. Fanta Sylla - First Female Minister of Justice, Mali. Samba Ousemane Sow - Physician, former Minister Of Health. Diarra Mariam Flantié Diallo - former Minister of Communication and New Technologies. Diallo Sène - former Minister for the Promotion of Women, Children, and the Family.
By 2016, regeneration had been operationalised and induced by four main techniques: regeneration by instrument; regeneration by materials; regeneration by 3D printing; and regeneration by drugs. By 2016, regeneration by instrument, regeneration by materials and by regeneration drugs had been generally operationalised in vivo (inside living tissues), while regeneration by 3D printing had been generally operationalised in vitro (inside the lab) in order to create and prepare tissue for transplantation.
Memphis International Airport (IATA: MEM, ICAO: KMEM, FAA LID: MEM), officially known as Frederick W. Smith International Airport, is a civil–military airport located seven miles (11 km; 6.1 nmi) southeast of downtown Memphis in Shelby County, Tennessee, United States. It is the primary airport serving Memphis. The airport covers 3,900 acres (1,600 ha) and has four runways. The airport is the "superhub" for FedEx Express, with the company operating nearly 400 flights per day from Memphis, mostly at night, to destinations including the continental United States, Canada, Europe, the Middle East, Asia, and South America. The airport averages about 80 passenger flights per day. The Memphis Air National Guard Base is located at the airport and houses the 164th Airlift Wing of the Tennessee Air National Guard, which operates C-17 Globemaster III transport aircraft. The airport opened in 1929. During World War II, it served as the base of the 4th Ferrying Group. A jet-age terminal opened in the 1960s. In 1973, Federal Express established its main hub at the airport. Memphis also served as a passenger hub from 1985 to 2013. Republic Airlines established the hub. After Republic merged with Northwest Airlines in 1986, Northwest continued to operate the hub. When Northwest subsequently merged with Delta Air Lines in 2008, it was considered redundant within Delta's network, and lost its hub status. The airport subsequently reduced its passenger facilities from three concourses to one. On August 11, 2026, the airport was renamed for Frederick W. Smith, founder of FedEx.
NA also promotes cell fusion, which helps the nascent virions to avoid contact with host antibodies and thus enables the virus to spread within tissues. cytotoxic T lymphocytes. Variable sialidases can cause this effect, including NA from Newcastle disease virus that have been shown to cleave 2,3-, 2,6-, and 2,8-linkages between sialic acid residues. In vitro, there was no significant difference between NAs from Newcastle disease virus, SeV and mumps virus with respect to substrate specificity. These results suggest that treating a tumor with the virus results in desialylation of malignant cells, which contributes to increased anti-tumor immune surveillance. Therefore, the ability of SeV sialidase (NA) to remove sialic acid from the surface of malignant cells most likely helps to ensure the availability of tumor antigens for recognition by cytotoxic T lymphocytes.
Sources: en.wikipedia.org
Pathology is the study of disease. The word pathology also refers to the study of disease in general, incorporating a wide range of biology research fields and medical practices. However, when used in the context of modern medical treatment, the term is often used in a narrower fashion to refer to processes and tests that fall within the contemporary medical field of "general pathology", an area that includes a number of distinct but inter-related medical specialties that diagnose disease, mostly through analysis of tissue and human cell samples. Pathology is a significant field in modern medical diagnosis and medical research. A physician practicing pathology is called a pathologist. As a field of general inquiry and research, pathology addresses components of disease: cause, mechanisms of development (pathogenesis), structural alterations of cells (morphologic changes), and the consequences of changes (clinical manifestations). In common medical practice, general pathology is mostly concerned with analyzing known clinical abnormalities that are markers or precursors for both infectious and non-infectious disease, and is conducted by experts in one of two major specialties, anatomical pathology and clinical pathology. Further divisions in specialty exist on the basis of the involved sample types (comparing, for example, cytopathology, hematopathology, and histopathology), organs (as in renal pathology), and physiological systems (oral pathology), as well as on the basis of the focus of the examination (as with forensic pathology).
=== Reactions with oxygen (combustion reaction) === All alkanes react with oxygen in a combustion reaction, although they become increasingly difficult to ignite as the number of carbon atoms increases. The general equation for complete combustion is:
McKew said that "Putin and his minions have spent the past 15 years ranting about how the West (specifically NATO) wants a new Cold War". She suggested that "fighting a new Cold War would be in America's interest", adding "We won the last Cold War. We will win the next one too". The New Republic editor Jeet Heer criticised McKew's suggestion as "troubling" and for "wildly overstating the extent of Russian ambitions and power". Heer said that unlike the old Cold War, "Current U.S. troubles with Russia aren't the result of ideological differences ... and are intensely localized along Russia's borders, in countries like the Ukraine and Georgia". Jeremy Shapiro, a senior fellow in the Brookings Institution, wrote in his blog post at RealClearPolitics, referring to the US–Russia relations: "A drift into a new Cold War has seemed the inevitable result" of "Russian–Western confrontation" over Eastern European counties such as Ukraine, Moldova and Georgia. In August 2017, Russian Deputy Foreign Minister Sergei Ryabkov denied claims that the US and Russia were having another cold war, despite ongoing tensions between the two countries over Ukraine and Syria, and newer US sanctions against Russia. The University of East Anglia graduate student Oliver Steward, as well as the Casimir Pulaski Foundation senior fellow Stanisław Koziej, attributed the Russia's Zapad 2017 exercise in Belarus as part of the new Cold War between Russia and the West.
=== Theatrical === The film was scheduled to release on 11 January 2020 but in November 2019, the release was preponed to 9 January to get the benefits of the extended holiday weekend because that year's Pongal fell on 15 January. Darbar opened in 7,000 screens worldwide, including 4,000 screens in India. On 7 January 2020, the Madras High Court blocked the film's release in Malaysia after its producer failed to pay a debt of ₹23 crore to its distributor. The court later revoked the claim after Lyca Productions showed a bank guarantee of ₹4.9 crores.
Sources: en.wikipedia.org
SR9009 is a synthetic research compound that binds and modulates the nuclear receptors REV-ERBα and REV-ERBβ. It is used in laboratory studies of circadian biology and metabolism, not as an approved medicine. It is also known by the informal name Stenabolic.
No. SR9009 has not been approved as a therapeutic drug in the United States, European Union, or other major markets. Human safety and efficacy data are very limited. Its presence in consumer products does not imply regulatory approval.
The World Anti-Doping Agency lists SR9009 as a prohibited substance because it can alter gene expression and metabolic pathways relevant to performance. The ban applies at all times, not only during competition. Detection relies on laboratory methods such as mass spectrometry.
It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.